Pros and cons of phage therapy.

Bacteriophage
Catherine Loc-Carrillo, S T Abedon

Abstract

Many publications list advantages and disadvantages associated with phage therapy, which is the use of bacterial viruses to combat populations of nuisance or pathogenic bacteria. The goal of this commentary is to discuss many of those issues in a single location. In terms of "Pros," for example, phages can be bactericidal, can increase in number over the course of treatment, tend to only minimally disrupt normal flora, are equally effective against antibiotic-sensitive and antibiotic-resistant bacteria, often are easily discovered, seem to be capable of disrupting bacterial biofilms, and can have low inherent toxicities. In addition to these assets, we consider aspects of phage therapy that can contribute to its safety, economics, or convenience, but in ways that are perhaps less essential to the phage potential to combat bacteria. For example, autonomous phage transfer between animals during veterinary application could provide convenience or economic advantages by decreasing the need for repeated phage application, but is not necessarily crucial to therapeutic success. We also consider possible disadvantages to phage use as antibacterial agents. These "Cons," however, tend to be relatively minor.

References

Jul 1, 1997·Trends in Microbiology·P A Barrow, J S Soothill
Nov 20, 1998·The Journal of Infection·J AliskyN Troitsky
Sep 7, 2001·Annual Review of Microbiology·W C Summers
Jan 21, 2003·Emerging Infectious Diseases·Charles W Stratton
Sep 11, 2003·Advances in Applied Microbiology·Ronald Bentley, J W Bennett
Apr 5, 2005·Indian Journal of Medical Sciences·Rashmi SharmaBhuvneshwar Kapoor
Jan 21, 2006·International Journal of Medical Microbiology : IJMM·Mikael Skurnik, Eckhard Strauch
Mar 17, 2007·Biotechnology Letters·Mikael SkurnikSaija Kiljunen
Jun 11, 2008·Research in Microbiology·Nicholas H Mann
May 23, 2009·Foodborne Pathogens and Disease·Stephen T Abedon
Aug 29, 2009·Science·Michael A Fischbach, Christopher T Walsh
Nov 26, 2009·The Journal of Infectious Diseases·Rosanna CapparelliDomenico Iannelli
Mar 2, 2010·Journal of Virological Methods·Petra KrambergerMatjaz Peterka
Jan 1, 2009·Current Pharmaceutical Biotechnology·Jason J Gill, Paul Hyman
Jan 1, 2009·Current Pharmaceutical Biotechnology·Lawrence D Goodridge
Jan 1, 2009·Current Pharmaceutical Biotechnology·Stephen T Abedon, Cameron Thomas-Abedon
Jan 1, 2009·Current Pharmaceutical Biotechnology·Elizabeth KutterStephen T Abedon
Apr 3, 2010·Advances in Applied Microbiology·Paul Hyman, Stephen T Abedon
May 29, 2010·Applied Microbiology and Biotechnology·Chang Ding, Jianzhong He
Sep 3, 2010·Trends in Biotechnology·Mzia Kutateladze, Revaz Adamia

❮ Previous
Next ❯

Citations

Mar 6, 2013·Viral Immunology·Aneta Kurzepa-SkaradzinskaAndrzej Gorski
Mar 25, 2011·Virology Journal·Pieter-Jan CeyssensMaya Merabishvili
Jan 1, 2012·Scientifica·Paul Hyman, Stephen T Abedon
May 25, 2013·Future Microbiology·Benjamin K ChanCatherine Loc-Carrillo
May 2, 2014·World Journal of Microbiology & Biotechnology·Sabah A A Jassim, Richard G Limoges
Jul 6, 2014·Viruses·Zuzanna KaźmierczakKrystyna Dąbrowska
May 20, 2015·Expert Opinion on Drug Discovery·Robert Penchovsky, Martina Traykovska
Nov 5, 2015·Expert Opinion on Investigational Drugs·Cuong VuongMichael Otto
Feb 23, 2013·Expert Opinion on Drug Discovery·Mario ZuccaDianella Savoia
Mar 5, 2016·World Journal of Microbiology & Biotechnology·Sabah A A JassimHassan El-Cheikh
Dec 19, 2015·International Forum of Allergy & Rhinology·Amanda J DrillingSarah Vreugde
Dec 1, 2015·Frontiers in Microbiology·Sari MattilaMatti Jalasvuori
Aug 31, 2012·International Journal of Microbiology·Rebekah A FramptonPeter C Fineran
Oct 3, 2012·Evolutionary Applications·Dominik Refardt
Aug 9, 2015·Biochemical Pharmacology·Shyam Sunder Chatterjee
Oct 7, 2015·Frontiers in Pharmacology·Hugo OliveiraJoana Azeredo
Dec 10, 2013·Veterinary Microbiology·Jessica TsonosRob Lavigne
Nov 6, 2013·The Journal of General Virology·Luís D R MeloNuno Cerca
Apr 9, 2015·Journal of Evolutionary Biology·F A GorterP D Scanlan
Mar 26, 2014·Microbiological Research·Anshul NigamAshwani Sharma
May 29, 2014·BioMed Research International·Gilbert VerbekenCarl Ceulemans
Aug 30, 2014·FEMS Microbiology Letters·Nika JanežMatjaž Peterka
May 22, 2013·BioMed Research International·Holger Brüggemann, Rolf Lood
Sep 23, 2014·Acta Orthopaedica·Herbert O GbejuadeJason C Webb
Apr 1, 2014·Upsala Journal of Medical Sciences·Anders S Nilsson
Mar 25, 2015·Critical Care Medicine·Nicolas DufourJean-Damien Ricard
May 16, 2015·Critical Care Medicine·Martin Witzenrath
Feb 25, 2015·Trends in Microbiology·Franklin L NobregaJoana Azeredo
Jul 1, 2011·Bacteriophage·Stephen T Abedon
Feb 16, 2012·Bacteriophage·Stephen T AbedonElizabeth Martin Kutter
Dec 3, 2014·Water Research·Thomas O Worley-Morse, Claudia K Gunsch
Jul 13, 2014·Burns : Journal of the International Society for Burn Injuries·Parul GuptaKusum Harjai
May 7, 2016·Chemical Society Reviews·Amy M Wen, Nicole F Steinmetz
Jun 4, 2016·Colloids and Surfaces. B, Biointerfaces·Shams Tabrez KhanAbdulaziz A Al-Khedhairy
Jun 25, 2015·PloS One·Mayukh DasCarlos F Gonzalez
Aug 16, 2016·Microbiological Research·Alessandra C RiosVictor M Balcão
Jul 23, 2016·Frontiers in Microbiology·Sana HamdiKarim B Slama

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Related Papers

Bacteriophage
S T AbedonElizabeth Martin Kutter
Current Pharmaceutical Biotechnology
S T Abedon, Cameron Thomas-Abedon
Nature Reviews. Microbiology
Bruce R Levin, James J Bull
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery
A WrightD R Harper
© 2022 Meta ULC. All rights reserved